These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 6300455)

  • 21. Synthesis of specific transformation-associated proteins (TAPs) in two rat cell lines is closely related to the expression of the v-mos gene product of Moloney murine sarcoma virus (Mo-MSV).
    Li W; Bowen JM; Chan JC
    Intervirology; 1987; 28(1):50-6. PubMed ID: 2828268
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparative tryptic peptide analysis of candidate P85gag-mos of ts110 Moloney murine sarcoma virus and P38-P23 mos gene-related proteins of wild-type virus.
    Murphy EC; Arlinghaus RB
    Virology; 1982 Sep; 121(2):372-83. PubMed ID: 6981878
    [No Abstract]   [Full Text] [Related]  

  • 23. Identification of proteins encoded by the Gazdar murine sarcoma virus genome by in vitro translation and comparison with Moloney murine sarcoma virus 124.
    Papkoff J; Hunter T
    J Virol; 1982 Aug; 43(2):533-43. PubMed ID: 6180181
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The transforming protein of Moloney murine sarcoma virus is a soluble cytoplasmic protein.
    Papkoff J; Nigg EA; Hunter T
    Cell; 1983 May; 33(1):161-72. PubMed ID: 6380747
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of myeloproliferative sarcoma virus with Moloney murine sarcoma virus variants by nucleotide sequencing and heteroduplex analysis.
    Stacey A; Arbuthnott C; Kollek R; Coggins L; Ostertag W
    J Virol; 1984 Jun; 50(3):725-32. PubMed ID: 6328002
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Transformation-resistant mos revertant is unable to activate MAP kinase kinase in response to v-mos or v-raf.
    Topol LZ; Marx M; Calothy G; Blair DG
    Cell Growth Differ; 1995 Jan; 6(1):27-38. PubMed ID: 7718484
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Monoclonal antibody detection of transformation associated protein (TAP) in ts110 Moloney murine sarcoma virus transformed 6M2 cells that are different from the mos gene product.
    Chan JC; Keck ME; Li W
    Biochem Biophys Res Commun; 1986 Feb; 134(3):1223-30. PubMed ID: 3004486
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The ts110 Moloney mouse sarcoma virus system: gag-mos gene products and cellular transformation.
    Arlinghaus RB
    J Gen Virol; 1985 Sep; 66 ( Pt 9)():1845-53. PubMed ID: 2993477
    [No Abstract]   [Full Text] [Related]  

  • 29. Characterization of viral polyproteins in cells transformed and producing Moloney murine sarcoma virus-124.
    Wood TG; Lyons DD; Ng VL; Murphy EC; Arlinghaus RB
    Biochim Biophys Acta; 1980 Jul; 608(2):215-31. PubMed ID: 6156703
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Monoclonal antibodies to the p21 products of the transforming gene of Harvey murine sarcoma virus and of the cellular ras gene family.
    Furth ME; Davis LJ; Fleurdelys B; Scolnick EM
    J Virol; 1982 Jul; 43(1):294-304. PubMed ID: 6287003
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Reversion of thermosensitive splicing defect of Moloney murine sarcoma virus ts110 by oversplicing of viral RNA.
    Hamelin R; Honore N; Sergiescu D; Singh B; Gerfaux J; Arlinghaus RB
    J Virol; 1990 Mar; 64(3):1378-82. PubMed ID: 2154617
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Nickel-induced heritable alterations in retroviral transforming gene expression.
    Biggart NW; Gallick GE; Murphy EC
    J Virol; 1987 Aug; 61(8):2378-88. PubMed ID: 3037102
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Murine retrovirus Pr65gag forms a 130K dimer in the absence of disulfide reducing agents.
    Yoshinaka Y; Katoh I; Luftig RB
    Virology; 1984 Jul; 136(2):274-81. PubMed ID: 6087546
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Isolation and characterization of a Mo-MuSV-transformed TB cell line that produces noninfectious MuSV particles with uncleaved gag protein which is processed in the presence of Mo-MuLV.
    Soong MM; Yuen PH; Wong PK
    Virology; 1984 Jan; 132(2):390-400. PubMed ID: 6322421
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhibition of viral mos gene-expression in transformed-cells restricts cell-cycle progression through g1-phase and g2-phase.
    Hamelin R; Planchon P; Singh B; Arlinghaus R
    Int J Oncol; 1992 Oct; 1(5):513-23. PubMed ID: 21584574
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Expression of transforming region of Moloney murine sarcoma virus in Escherichia coli as a fusion protein with small tumor antigen of polyoma virus.
    Donoghue DJ; Hunter T
    Proc Natl Acad Sci U S A; 1982 Feb; 79(3):800-4. PubMed ID: 6278495
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antibodies against small nuclear ribonucleoproteins immunoprecipitate complexes containing ts110 Moloney murine sarcoma virus genomic and messenger RNAs.
    Hamelin R; Chan EK; Tan EM; Arlinghaus RB
    Virology; 1986 Jul; 152(1):87-99. PubMed ID: 3012876
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of the genomic organization of Kirsten and Harvey sarcoma viruses.
    Shih TY; Williams DR; Weeks MO; Maryak JM; Vass WC; Scolnick EM
    J Virol; 1978 Jul; 27(1):45-55. PubMed ID: 211254
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Molecular basis underlying phenotypic revertants of Moloney murine sarcoma virus MuSVts110.
    Cizdziel PE; Nash MA; Blair DG; Murphy EC
    J Virol; 1986 Jan; 57(1):310-7. PubMed ID: 3001354
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Rates of evolution of the retroviral oncogene of Moloney murine sarcoma virus and of its cellular homologues.
    Gojobori T; Yokoyama S
    Proc Natl Acad Sci U S A; 1985 Jun; 82(12):4198-201. PubMed ID: 2987967
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.